TG THERAPEUTICS INC revenue breakdown overview

TG THERAPEUTICS INC revenue for the last year amounted to 211.70 M EUR, the most of which — 211.70 M EUR — came from its highest performing source at the moment, Novel Treatments for B-cell Diseases, the year earlier bringing 2.60 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought TG THERAPEUTICS INC 211.70 M EUR, and the year before that — 2.60 M EUR.